Annual Shareholders Equity
-$5.79 M
-$9.69 M-248.74%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual stockholders equity is -$5.79 million, with the most recent change of -$9.69 million (-248.74%) on December 31, 2023.
- During the last 3 years, EFTR annual shareholders equity has risen by +$126.45 million (+95.62%).
- EFTR annual shareholders equity is now -133.53% below its all-time high of $17.28 million, reached on December 31, 2021.
Performance
EFTR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$827.00 K
+$6.62 M+114.27%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly stockholders equity is $827.00 thousand, with the most recent change of +$6.62 million (+114.27%) on March 31, 2024.
- Over the past year, EFTR quarterly shareholders equity has increased by +$5.64 million (+117.18%).
- EFTR quarterly shareholders equity is now -96.72% below its all-time high of $25.23 million, reached on March 31, 2022.
Performance
EFTR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EFTR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -248.7% | +117.2% |
| 3 y3 years | +95.6% | +117.2% |
| 5 y5 years | +95.6% | +117.2% |
EFTR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -133.5% | at low | -96.7% | +114.3% |
| 5 y | 5-year | -133.5% | +95.6% | -96.7% | +100.6% |
| alltime | all time | -133.5% | +95.6% | -96.7% | +100.6% |
EFFECTOR Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $827.00 K(-114.3%) |
| Dec 2023 | -$5.79 M(-248.7%) | -$5.79 M(+46.1%) |
| Sep 2023 | - | -$3.97 M(-254.0%) |
| Jun 2023 | - | $2.58 M(-153.5%) |
| Mar 2023 | - | -$4.81 M(-223.5%) |
| Dec 2022 | $3.90 M | $3.90 M(-66.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $11.56 M(-41.1%) |
| Jun 2022 | - | $19.62 M(-22.2%) |
| Mar 2022 | - | $25.23 M(+46.0%) |
| Dec 2021 | $17.28 M(-113.1%) | $17.28 M(-325.4%) |
| Sep 2021 | - | -$7.67 M(-94.2%) |
| Dec 2020 | -$132.25 M | -$132.25 M |
FAQ
- What is eFFECTOR Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual shareholders equity year-on-year change?
- What is eFFECTOR Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly shareholders equity year-on-year change?
What is eFFECTOR Therapeutics annual stockholders equity?
The current annual shareholders equity of EFTR is -$5.79 M
What is the all time high annual shareholders equity for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual stockholders equity is $17.28 M
What is eFFECTOR Therapeutics annual shareholders equity year-on-year change?
Over the past year, EFTR annual stockholders equity has changed by -$9.69 M (-248.74%)
What is eFFECTOR Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of EFTR is $827.00 K
What is the all time high quarterly shareholders equity for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly stockholders equity is $25.23 M
What is eFFECTOR Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, EFTR quarterly stockholders equity has changed by +$5.64 M (+117.18%)